✦ LIBER ✦

Sapacitabine phase II trial in AML expanded to assess MDS

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

162. Phase II clinical trial with hexame

✍ Michaeli, J; Andreeff, M; Stone, R; Young, CL; Kufe, D; Rifkind, RA; Marks, Pa 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 131 KB

COLT, Multicenter CaPre Open Label Rando

✍ Sampalis, Tina; Pesant, Yves; Pouliot, Joel; Elliott, Thomas; Tsoukas, George; G 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 200 KB

A phase II trial to assess efficacy and

✍ Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Mar 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 303 KB

221 A phase II trial to assess the safet

✍ Lester, J.F.; Casbard, A.; Roberts, K.; Tabi, Z.; Griffiths, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II, open-label trial to assess QTc

✍ Molife, L. Rhoda; Rudman, Sarah M.; Alam, Salma; Tan, Daniel S.-W.; Kristeleit, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 697 KB

Phase II trial to assess the safety and

✍ Martínez-Cuadrón, David; Montesinos, Pau; Oriol, Albert; Salamero, Olga; Vidrial 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 102 KB